Advertisement
  • September 17: The Week in Cancer News

    An immunotherapy combination continues to be effective in treating kidney cancer patients, and the FDA approves a therapy for a type of lung cancer.

    by Kevin McLaughlin

  • Forward Look

    There’s Time to Consider Fertility Preservation Options

    Women with breast cancer who choose fertility preservation have treatment outcomes similar to women who don't undergo fertility preservation.

    by Kris Conner

  • September 10: The Week in Cancer News

    9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers

    by Marci A. Landsmann

  • Healthy Habits

    Mushroom for Improvement

    A broad review of existing research finds eating more mushrooms is associated with lower risk of developing cancer.

    by Ashley P. Taylor

  • September 3: The Week in Cancer News

    Researchers investigate how antibiotics might increase the risk of colon cancer, and the FDA approves a treatment for Waldenström macroglobulinemia.

    by Bradley Jones

  • An Emerging Treatment for Metastatic Prostate Cancer

    A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.

    by Pamela Rafalow Grossman

  • August 27: The Week in Cancer News

    Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.

    by Bradley Jones

  • August 20: The Week in Cancer News

    Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

    by Marci A. Landsmann

  • Forward Look

    What’s Next?

    Early detection of brain cancer.

    by Carisa Brewster

  • August 13: The Week in Cancer News

    Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

    by Kevin McLaughlin